Clinician offering is a key factor associated with HPV vaccine uptake among Mexican mothers in the USA and Mexico: a cross-sectional study
- 98 Downloads
To compare the knowledge, beliefs, and practices regarding HPV vaccination among mothers of vaccine-eligible girls in Mexico and the USA.
Similar samples of Mexican mothers with vaccine-eligible daughters were surveyed at two clinics in Cuernavaca, Morelos, from July to October 2012 (n = 200) and at two clinics in Oxnard, California, from August to November 2013 (n = 200).
Although mothers in the USA had less knowledge and more negative attitudes toward the vaccine than their counterparts in Mexico, vaccine uptake rates were higher in the USA (49% vs. 40%). US mothers were more likely to have discussed and been offered the HPV vaccine by a clinician than mothers in Mexico. In multivariate analyses, having been offered the HPV vaccine was the most important predictor of vaccine uptake.
Our results suggest that healthcare access or other system, clinic, or provider factors are the main drivers of vaccine receipt in this binational sample of Mexican mothers. Interventions and programs that encourage clinicians to offer the HPV vaccine should be developed to increase vaccine uptake in both countries.
KeywordsHuman papillomavirus Vaccination Cervical cancer prevention Health disparities Mexico Latinos
This work was supported by the Programa de Investigación en Migracion y Salud (PIMSA), Berkeley, CA, the Mexican Institute of Social Security [grant number FIS/IMSS/PROT/G11/970], and the UCLA Kaiser Permanente Center for Health Equity. YNF was also supported by NIH/NCI K07CA197179. The authors would like to thank the study participants and our collaborators at Clinicas del Camino Real (Dr. Gagan Pawar, Patricia Andrade and Laura Aguiniga), IMSS (Griselda Diaz, Lucy Cruz), and UCLA (Mayra Macias).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests to disclose.
All study procedures were performed in accordance with the ethical standards of the UCLA and IMSS research committees and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
- American Cancer Society (2018) Key statistics for cervical cancer? https://www.cancer.org/cancer/cervical-cancer/about/key-statistics.html. Accessed 7 July 2018
- American Cancer Society, California Department of Public Health, California Cancer Registry (2017) California cancer facts & figures 2017. American Cancer Society, Inc. California Division, Alameda. http://www.ccrcal.org/pdf/Reports/ACS_2017_FF.pdf. Accessed 7 July 2018
- Bruni L, Diaz M, Barrionuevo-Rosas L, Herrero R, Bray F, Bosch FX, de Sanjosé S, Castellsagué X (2016) Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Glob Health 4(7):e453–e463. https://doi.org/10.1016/s2214-109x(16)30099-7 CrossRefGoogle Scholar
- Bruni L, Barrionuevo-Rosas L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, Bosch FX, de Sanjosé S (2017) ICO information centre on HPV and cancer (HPV information centre). Human papillomavirus and related diseases in Mexico. Summary report. https://www.hpvcentre.net/statistics/reports/MEX.pdf. Accessed 7 July 2018
- Centers for Disease Control and Prevention (2011) Progress toward implementation of human papillomavirus vaccination—the Americas, 2006–2010. MMWR Morb Mortal Wkly Rep 60(40):1382–1384. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6040a2.htm. Accessed 7 July 2018
- Centers for Disease Control and Prevention (2014) Vaccines for children program (VFC). https://www.cdc.gov/vaccines/programs/vfc/about/index.html. Accessed 7 July 2018
- Centers for Disease Control and Prevention (2018) Cervical cancer statistics. https://www.cdc.gov/cancer/cervical/statistics/index.htm. Accessed 7 July 2018
- Elam-Evans LD, Yankey D, Jeyarajah J, Singleton JA, Curtis RC, MacNeil J, Hariri S, Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC) (2014) National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2013. MMMW 63(29):625–633. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6329a4.htm. Accessed 7 July 2018
- Fernandez ME, McCurdy SA, Arvey SR, Tyson SK, Morales-Campos D, Flores B, Useche B, Mitchell-Bennett L, Sanderson M (2009) HPV knowledge, attitudes, and cultural beliefs among Hispanic men and women living on the Texas-Mexico border. Ethn Health 14(6):607–624. https://doi.org/10.1080/13557850903248621 CrossRefGoogle Scholar
- Instituto Nacional de Estadística y Geografía (INEGI) (2013) Encuesta Nacional de Empleo y Seguridad Social (ENESS) http://www.beta.inegi.org.mx/proyectos/enchogares/modulos/eness/2013/. Accessed 7 July 2018
- Liu L, Wang Y, Sherman RL, Cockburn M, Deapen D (eds) (2016) Cancer in Los Angeles county: trends by race/ethnicity, 1976–2012. Los Angeles Cancer Surveillance Program, University of Southern California. http://keck.usc.edu/cancer-surveillance-program/wp-content/uploads/sites/166/2016/08/Cancer-in-LA-2016.pdf. Accessed 7 July 2018
- Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER (2007) Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP). MMWR 56 (RR-2):1–24. https://www.cdc.gov/mmwr/PDF/rr/rr5602.pdf. Accessed 7 July 2018
- Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER (2014) Human papillomavirus vaccination: recommendations of the advisory committee on immunization practices (ACIP). MMWR 63(5):1–30. https://www.cdc.gov/mmwr/pdf/rr/rr6305.pdf. Accessed 7 July 2018
- Newman PA, Logie CH, Lacombe-Duncan A, Baiden P, Tepjan S, Rubincam C, Doukas N, Asey F (2018) Parents’ uptake of human papillomavirus vaccines for their children: a systematic review and meta-analysis of observational studies. BMJ Open 8(4):e019206. https://doi.org/10.1136/bmjopen-2017-019206 CrossRefGoogle Scholar
- Petrosky E, Bocchini JA, Hariri S, Chesson H, Curtis CR, Saraiya M, Unger ER, Markowitz LE (2015) Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMMW 64(11);300–304. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6411a3.htm. Accessed 7 July 2018
- Sánchez Anguiano LF, Lechuga Quiñones AM, Milla Villeda RH, Lares Bayona EF (2013) Knowledge and acceptance of vaccine against human papillomavirus among mothers of students from Durango City, Mexico. Ginecol Obstet Mex 81(2):77–85Google Scholar
- Tsui J, Singhal R, Rodriguez HP, Gee GC, Glenn BA, Bastani R (2013) Proximity to safety-net clinics and HPV vaccine uptake among low-income, ethnic minority girls. Vaccine 31(16):2028–2034. https://doi.org/10.1016/j.vaccine.2013.02.046;PMCID:PMC3629820 CrossRefGoogle Scholar
- Walker TY, Elam-Evans LD, Singleton JA, Yankey D, Markowitz LE, Fredua B, Williams CL, Meyer SA, Stokley S (2017) National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2016. MMWR Morb Mortal Wkly Rep 66:874–882. https://doi.org/10.15585/mmwr.mm6633a2 CrossRefGoogle Scholar